Randomized phase II study of pemetrexed plus carboplatin followed by pemetrexed versus paclitaxel plus carboplatin followed by pemetrexed in advanced nonsquamous, non-small cell lung cancer (LOGIK 0904)

被引：0
|
作者：
Takayama, Koichi
Inoue, Koji
Takeshita, Masafumi
Tashiro, Naoki
Harada, Taishi
Seto, Takashi
Imanaga, Tomotoshi
Fujimoto, Noriko
Nakagaki, Noriaki
Kawasaki, Masayuki
Kishimoto, Junji
Ichinose, Yukito
机构：
[1] Kyushu Univ, Res Inst Dis Chest, Grad Sch Med Sci, Fukuoka 812, Japan
[2] Kitakyushu Municipal Med Ctr, Dept Resp Med, Kitakyushu, Fukuoka, Japan
[3] Fukuoka Univ, Sch Med, Dept Resp Med, Fukuoka 81401, Japan
[4] Kyushu Natl Canc Ctr, Dept Med Oncol, Fukuoka, Japan
[5] Steel Mem Yawata Hosp, Dept Resp Dis, Kitakyushu, Fukuoka, Japan
[6] St Marys Hosp, Dept Resp Dis, Kurume, Fukuoka, Japan
[7] Natl Hosp Org Fukuoka Higashi Med Ctr, Dept Resp Dis, Fukuoka, Japan
[8] Natl Hosp Org Omuta Hosp, Dept Resp Med, Omuta, Japan
[9] Kyushu Univ Hosp, Ctr Clin & Translat Res, Fukuoka 812, Japan
[10] Kyushu Natl Canc Ctr, Clin Res Inst, Fukuoka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8111
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A Randomized Phase II Study of Maintenance Bevacizumab, Pemetrexed or Bevacizumab Plus Pemetrexed for Advanced Non-squamous Non-small Cell Lung Cancer
    Yoshida, Hironori
    Kim, Young Hak
    Sakamori, Yuichi
    Nagai, Hiroki
    Ozasa, Hiroaki
    Kaneda, Toshihiko
    Yoshioka, Hiroshige
    Nakagawa, Hiroaki
    Tomii, Keisuke
    Okada, Asuka
    Yoshimura, Kenichi
    Hirabayashi, Masataka
    Hirai, Toyohiro
    [J]. ANTICANCER RESEARCH, 2020, 40 (05) : 2981 - 2987
  • [42] FINAL ANALYSIS OF DOSE ESCALATION STUDY OF CARBOPLATIN PLUS PEMETREXED FOLLOWED BY MAINTENANCE PEMETREXED FOR ELDERLY PATIENTS (≥75 YEARS OLD) WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
    Tamiya, Motohiro
    Tamiya, Akihiro
    Shiroyama, Takayuki
    Kanazu, Masaki
    Hirooka, Aya
    Tsuji, Taisuke
    Morishita, Naoko
    Asami, Kazuhiro
    Suzuki, Hidekazu
    Okamoto, Norio
    Okishio, Kyoichi
    Kawaguchi, Tomoya
    Hirashima, Tomonori
    Atagi, Shinji
    Kawase, Ichiro
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1162 - S1163
  • [43] Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study
    Tsutani, Yasuhiro
    Miyata, Yoshihiro
    Masuda, Takeshi
    Fujitaka, Kazunori
    Doi, Mihoko
    Awaya, Yoshikazu
    Kuyama, Shoichi
    Kitaguchi, Soichi
    Ueda, Kazuhiro
    Hattori, Noboru
    Okada, Morihito
    [J]. BMC CANCER, 2018, 18
  • [44] Phase 2 Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin with Concurrent Radiation Therapy Followed by Pemetrexed Consolidation in Patients with Favorable-Prognosis Inoperable Stage IIIA/B Non-Small-Cell Lung Cancer
    Choy, Hak
    Schwartzberg, Lee S.
    Dakhil, Shaker R.
    Garon, Edward B.
    Gerber, David E.
    Choksi, Janak K.
    Govindan, Ramaswamy
    Peng, Guangbin
    Koustenis, Andrew
    Treat, Joseph
    Obasaju, Coleman
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (10) : 1308 - 1316
  • [45] Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study
    Yasuhiro Tsutani
    Yoshihiro Miyata
    Takeshi Masuda
    Kazunori Fujitaka
    Mihoko Doi
    Yoshikazu Awaya
    Shoichi Kuyama
    Soichi Kitaguchi
    Kazuhiro Ueda
    Noboru Hattori
    Morihito Okada
    [J]. BMC Cancer, 18
  • [46] Multicenter phase II study of cisplatin, pemetrexed, plus bevacizumab followed by maintenance pemetrexed plus bevacizumab for patients with advanced or recurrent non-squamous non-small cell lung cancer: MAP study
    Tsutani, Y.
    Miyata, Y.
    Masuda, T.
    Fujitaka, K.
    Doi, M.
    Awaya, Y.
    Kuyama, S.
    Kitaguchi, S.
    Ueda, K.
    Okada, M.
    [J]. ANNALS OF ONCOLOGY, 2017, 28 : 137 - 137
  • [47] Randomized phase II study comparing cisplatin plus pemetrexed plus bevacizumab with carboplatin plus paclitaxel plus bevacizumab in treatment-naive advanced non-squamous non-small cell lung cancer (CLEAR study)
    Koyama, R.
    Udagawa, H.
    Sugiyama, E.
    Komuta, K.
    Mori, M.
    Yokoyama, T.
    Sasaki, T.
    Saito, H.
    Ishida, H.
    Nakagawa, H.
    Sekine, A.
    Tamura, A.
    Shingyoji, M.
    Mizuno, K.
    Nakamura, A.
    Kinoshita, A.
    Yamanaka, T.
    Goto, K.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [48] COST UTILITY ANALYSIS OF FIRST-LINE PACLITAXEL WITH CARBOPLATIN AND BEVACIZUMAB FOLLOWED BY MAINTENANCE BEVACIZUMAB VERSUS PEMETREXED WITH CARBOPLATIN FOLLOWED BY MAINTENANCE PEMETREXED IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER IN LEBANON
    Tfayli, A.
    Elias, F.
    Farhat, F.
    Slim, R.
    Hallal, Z.
    Maatouk, L.
    Ibrahim, A.
    Anan, I
    [J]. VALUE IN HEALTH, 2018, 21 : S47 - S47
  • [49] A Randomized Phase II Study of Maintenance Bevacizumab, Pemetrexed, or Bevacizumab plus Pemetrexed in Advanced Nonsquamous Non-Small Cell Lung Cancer (Kyoto Thoracic Oncology Research Group 1101)
    Kaneda, T.
    Yoshida, H.
    Sakamori, Y.
    Nagai, H.
    Ozasa, H.
    Hirai, T.
    Yoshioka, H.
    Nakagawa, H.
    Tomii, K.
    Okada, A.
    Yoshimura, K.
    Hirabayashi, M.
    Kim, Y. H.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [50] A phase II study of metformin plus pemetrexed and carboplatin in patients with non-squamous non-small cell lung cancer (METALUNG)
    S. Verma
    S. Chitikela
    V. Singh
    S. Khurana
    D. Pushpam
    D. Jain
    S. Kumar
    Y. Gupta
    P. S. Malik
    [J]. Medical Oncology, 40
12345